¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"molecular lesion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇа˻ç
  • molecular genetics
    ºÐÀÚÀ¯ÀüÇÐ
  • molecular grating
    ºÐÀÚ°ÝÀÚ
  • molecular heat
    ºÐÀÚ¿­
  • molecular layer
    ºÐÀÚÃþ
  • molecular magnet
    ºÐÀÚÀÚ¼®
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • molecular mimicry
    ºÐÀÚ¸ð¹æ
  • molecular neurobiology
    ºÐÀڽŰæ»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ¹èÇâ
  • molecular physiology
    ºÐÀÚ»ý¸®ÇÐ
  • molecular radiation biology
    ºÐÀÚ¹æ»ç¼±»ý¹°ÇÐ
  • molecular refraction
    ºÐÀÚ±¼Àý
  • molecular sieve
    ºÐÀÚü
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µ·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular grating
    ºÐÀÚ°ÝÀÚ
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • molecular heat
    ºÐÀÚ¿­
  • molecular hypothesis
    ºÐÀÚ°¡¼³
  • molecular layer
    ºÐÀÚÃþ
  • molecular
    ºÐÀÚ-
  • molecular magnet
    ºÐÀÚÀÚ¼®
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • molecular mimicry
    ºÐÀÚ¸ð¹æ
  • molecular neurobiology
    ºÐÀڽŰæ»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ¹èÇâ
  • molecular physiology
    ºÐÀÚ»ý¸®ÇÐ
  • molecular refraction
    ºÐÀÚ±¼Àý
  • molecular sieve
    ºÐÀÚü
  • molecular spectrum
    ºÐÀÚ½ºÆåÆ®·³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radial sclerosing lesion
    ¹æ»ç¼º °æÈ­¼º º´º¯
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intracranial expanding lesion
    µÎ°³³»ÆØÃ¢¼º º´º¯(¡­ø³óìàõܻܨ).
  • lesion
    º´º¯
  • lower motor neuron lesion
    ÇϿ½Å°æ¿ø º´¼Ò
  • metastatic malignant lesion
    ÀüÀ̼º ¾Ç¼º º´ º¯(¡­ç÷àõܻܨ).
  • metastatic malignant lesion
    ÀüÀ̼º ¾Ç¼º º´º¯(¡­ç÷àõܻܨ)
  • nervous lesion
    ½Å°æ°èº´º¯.
  • nil lesion
    ¹Ì¼Òº´º¯(Ú°á³Ü»Ü¨)
  • nil lesion disease
    ¹Ì¼Òº¯È­ »ç±¸Ã¼½Å¿°(=minimal change disease)
  • onionskin lesion
    ¾çÆÄ²®Áúº´º¯(º´¼Ò)
  • organic lesion
    ±âÁúÀû º´º¯(¡­Ü»Ü¨).
  • organic lesion
    ±âÁúÀû º´º¯(ѨòõîÜܻܨ)
  • peripheral lesion
    ¸»Ãʼº º´º¯(ØÇôþàõ ܻܨ)
  • plexiform lesion
    Ãѻ󺴼Ò(º´º¯)(õ¿ßÒÜ»áµ(ܻܨ))
  • precancerous lesion
    ¾ÏÀü±¸º´º¯.
  • precancerous lesion
    Àü¾Ï¼º º´º¯(îñäßàõ ܻܨ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular orbital theory
    ºÐÀڱ˵µ¼³(ÝÂí­ÏùÔ³àã)
  • molecular photosensitization
    ºÐÀÚ ±¤°¨ÀÛ(ÝÂí­ÎÃÊõíÂ)
  • molecular radioautography
    ºÐÀÚ ¹æ»ç¼±ÀÚ°¡±â·Ï¹ý(ÝÂí­Û¯ÞÒàÊí»Ê«ÑÀÖâÛö)
  • molecular rotation
    ºÐÀÚȸÀü(ÝÂí­üÞï®)
  • molecular sieve
    ºÐÀÚ(ÝÂí­)ä
  • molecular sieve chromatography
    ºÐÀÚ(ÝÂí­)ä Å©·Î¸¶Åä±×¶óÇÇ
  • molecular sieve coefficient
    ºÐÀÚ(ÝÂí­)ä °è¼ö(Ìõâ¦)
  • molecular surface
    ºÐÀÚÇ¥¸é(ÝÂí­øúØü)
  • molecular taxonomy
    ºÐÀÚ ºÐ·ùÇÐ(ÝÂí­ÝÂ×¾ùÊ)
  • molecular vibration
    ºÐÀÚ Áøµ¿(ÝÂí­òèÔÑ)
  • molecular weight
    ºÐÀÚ·®(ÝÂí­Õá)
  • molecular weight average
    ºÐÀÚ·® Æò±Õ(ÝÂí­ÕáøÁг)
  • neutral theory of molecular evolution
    Á߸³ºÐÀÚÁøÈ­·Ð(ñ騡ÝÂí­òäûùÖå)
  • number-average molecular weight
    ¹«Æò±ÕºÐÀÚ·®(ÙíøÁгÝÂí­Õá)
  • target molecular weight
    Ç¥ÀûºÐÀÚ·® (øöîÜÝÂí­Õá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • systemic lesion
    Àü½Å¼ºº´º¯
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BLEL benign lympho-epithelial lesion
BPL benign proliferative lesion; benzyl penicilloyl-polylysine; beta-propiolactone
DMNL dorsomedial hypothalamic nucleus lesion
E* lesion on the erythrocyte cell membrane at the site of complement fixation
HSIL high-grade squamous intraepithelial lesion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HSIL High Grade Squamous Intraepithelial Lesion
LSIL Low Grade Squamous Intraepithelial Lesion
LEL Lymphoepithelial lesion
PSL pigmented skin lesion
SIL Squamous intraepithelial lesion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecular genetics
    ºÐÀÚ À¯ÀüÇÐ
  • molecular heat
    ºÐÀÚ ¿­
  • molecular layer
    ºÐÀÚ Ãþ
  • molecular magnet
    ºÐÀÚ ÀÚ¼®
  • molecular miocrobiology
    ºÐÀÚ ¹Ì»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ ¹èÇâ
  • molecular physiology
    ºÐÀÚ »ý¸®ÇÐ
  • molecular rearrangement
    ºÐÀÚ Àç¹è¿­
  • molecular shape
    ºÐÀÚ Çü»ó
  • molecular site
    ºÐÀÚ À§
  • molecular still
    ºÐÀÚ Áõ·ù±â
  • molecular tension
    ºÐÀÚ Àå·Â
  • molecular tumbling
    ºÐÀÚ ÅÒºí¸µ
  • molecular virology
    ºÐÀÚ ¹ÙÀÌ·¯½ºÇÐ
  • molecular weight
    ºÐÀÚ·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
coin lesion of lungs A solitary, round, circumscribed shadow found in the lung on chest radiograph; causes include granuloma, primary or metastatic carcinoma, benign tumour, vascular malformation.
Synonym: coin lesion of lungs.
(05 Mar 2000)
coin lesion, pulmonary Solitary, round, circumscribed shadows found in the lungs in X-ray examinations. Common causes are tuberculosis, neoplasms, cysts, or vascular anomalies.
(12 Dec 1998)
cold liver lesion <radiology> Size for detection = 1-2 cm (3-cm deep lesions), primary tumour (haemangioma hot by Tc-RBCs), metastasis, inflammatory lesion (e.g., amebic abscess), degenerative disease, trauma, congenital lesion (solitary cyst or polycystic disease) see: liver-spleen scan
(12 Dec 1998)
cold spleen lesion <radiology> Infarction, lymphoma, haematoma, tumour, splenic artery aneurysm, pancreatic pseudocyst, variant, artifact, absent spleen, splenectomy, sickle cell disease, trauma see: liver-spleen scan
(12 Dec 1998)
wire-loop lesion Thickening of the basement membrane, with fibrinoid staining, of scattered peripheral capillaries in renal glomeruli; characteristic of renal involvement in systemic lupus erythematosus; the appearance of an affected capillary wall resembles a loop used in microbiology.
(05 Mar 2000)
Councilman's lesion An eosinophilic globule, seen in the liver in yellow fever, derived from necrosis of a single hepatic cell.
Synonym: Councilman's lesion.
(05 Mar 2000)
precancerous lesion A noninvasive lesion with a predictable likelihood of becoming malignant; e.g., actinic keratosis.
(05 Mar 2000)
Hill-Sachs lesion An irregularity seen in the head of the humerus following dislocation of the shoulder; caused by impaction of the head of the humerus against the edge of the glenoid.
(05 Mar 2000)
hot liver lesion <radiology> Vena cava (superior vena cava/IVC) obstruction, QUADRATE (anterior medial segment of left lobe), basilic vein injection most likely to be collaterals, Budd-Chiari syndrome, CAUDATE lobe, cirrhosis, focal nodular hyperplasia (FNH), haemangioma see also: liver-spleen scan
(12 Dec 1998)
single lucent skull lesion <radiology> Mnemonic: HELP ME, haemangioma, epidermoid / dermoid, leptomeningeal cyst, lambdoid suture defect, Paget's (osteoporosis circumscripta), post-surgical, metastasis (solitary), eosinophilic granuloma, encephalocele
(12 Dec 1998)
solid lesion of spleen <radiology> Granulomatous disease, most often TB and histoplasmosis, less often sarcoid, metastasis, melanoma, lymphoma, breast, lung, primary mass, haemangioma, haemangiosarcoma, lymphangioma, infarction
(12 Dec 1998)
squamous intraepithelial lesion A general term for the abnormal growth of squamous cells on the surface of the cervix. The changes in the cells are described as low grade or high grade, depending on how much of the cervix is affected and how abnormal the cells are. Also called sil.
(12 Dec 1998)
dark t2 lesion <radiology> (short T2), acute haemorrhage (deoxyHb), haemosiderin, physiologic iron (basal ganglia, etc.), mucinous lesions (?) most abnormalities have long T1 and T2 (dark/bright).
Compare: bright T1 lesion.
(07 Mar 2000)
supranuclear lesion Injury to cerebral descending (corticonuclear) fibres above the brainstem or spinal motor nerve nucleus.
Synonym: upper motor neuron lesion.
(05 Mar 2000)
Dreulofoy's lesion An abnormally large submucosal artery located in the proximal stomach that may be the site of acute and recurrent episodes of massive haemorrhage.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á